Filing Details

Accession Number:
0001839882-23-006255
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-08 16:12:01
Reporting Period:
2023-03-06
Accepted Time:
2023-03-08 16:12:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1599298 Summit Therapeutics Inc. SMMT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055919 W Robert Duggan 611 South Fort Harrison Ave
Suite 306
Clearwater FL 33756
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-06 376,489,880 $1.05 552,354,161 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.